pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$AMGNAMGEN INC

$AMGN412.33-1.32%
Thousand Oaks, CA, USupdated 2h ago

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval84 co-mentions · 42 sources
  • drugOTEZLA28 co-mentions · 14 sources
  • drugAMJEVITA26 co-mentions · 13 sources
  • drugapremilast14 co-mentions · 14 sources
  • drugBKEMV14 co-mentions · 7 sources
  • drugapremilast ER14 co-mentions · 14 sources
  • tagSmall Molecule14 co-mentions · 14 sources
  • drugHUMIRA13 co-mentions · 13 sources
pipeline
33
marketed
20
phase 3
4
catalysts ytd
5
approvals ytd
2
recalls ytd
0

Pipeline(33)

view full pipeline →
pipeline depth33 products
Preclinical: 1Phase 1: 1Phase 2: 1Phase 3: 4Marketed: 20Unknown: 6
1Preclinical1Phase 11Phase 24Phase 320Marketed6Unknown
Marketed
AMJEVITA
Tumor necrosis factor
Marketed
Corlanor
Congestive Heart Failure (Heart Failure)
Marketed
WEZLANA
Marketed
Xgeva
Bone Metastasis
Marketed
apremilast ER
Behcet Disease
Marketed
blinatumomab
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
B-lymphocyte antigen CD19T cell surface glycoprotein CD3
Marketed
carfilzomib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
26S proteasome
Marketed
darbepoetin alfa LA
Anemia in Chronic Kidney Disease (Renal Anemia)
Marketed
denosumab
Glucocorticoid-Induced Osteoporosis
Marketed
eculizumab biosimilar
Paroxysmal Nocturnal Hemoglobinuria
Marketed
epoetin alfa
Chemotherapy Induced Anemia
Marketed
erenumab
Migraine

📅 Upcoming

Nov 3, 2026
earnings
$AMGN412.33-1.32%
in 3mo
AMGEN INC earnings
AMGEN INC
→

🕒 Recent(90d)

earnings (1)
Aug 4, 2026
earnings
$AMGN412.33-1.32%
10d ago
AMGEN INC earnings
AMGEN INC
→
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Feb 26, 26SELLSantos Esteban· EVP, Operations30,501 sh @ $379.12−$11.56M↗
  • Feb 26, 26SELLSantos Esteban· EVP, Operations24,291 sh @ $379.12−$9.21M↗
  • Feb 19, 26SELLBusch Matthew C.· VP, Finance & CAO1,000 sh @ $375.79−$376K↗
routine RSU / option mechanics (6)
  • Mar 16, 26tax coverBradway Robert A · Chairman, CEO and President21,294 sh
  • Mar 16, 26tax coverGordon Murdo · EVP, Global Commercial Ops6,691 sh
  • Mar 16, 26tax coverREESE DAVID M · EVP & Chief Technology Officer6,022 sh
  • Mar 16, 26tax coverGriffith Peter H. · EVP & CFO5,748 sh
  • Mar 16, 26tax coverSantos Esteban · EVP, Operations5,621 sh
  • Mar 16, 26tax coverGraham Jonathan P · EVP & Gen. Counsel & Sec.5,353 sh
🐶 Hiring Signal
next earnings Nov 3, 2026
1,657 open roles at AMGEN INC →

Where AMGEN INC is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaOncology 586Metabolic 46Cardiovascular 41Rare Disease 35Immunology & Inflammation 22CNS / Neuroscience 6
departmentIT & Engineering 398Manufacturing / CMC 302Commercial 168Business Development & Sales 134R&D / Discovery 115Biostatistics / Data 88

News

no news has mentioned this company yet
identifiers
ticker
$AMGN
SEC CIK
0000318154
country
US
source
sec_tickers
top tags
Oncology10Cardiology2Immunology2Asthma1Hyperlipidemia1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 8m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?